The Gut-Brain Axis in Anxiety and Depressive Disorders: From Microbiome Alterations to Novel Therapeutic Strategies
Ismail Ahmad, Faheem Kamran, Nadia Akhtar, Muhammad Irfan Khan, Muhammad Zaman ul Haq, Adnan Ullah Khan · African Journal of Biomedical Research · 2026
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
African Journal of Biomedical Research · African Journals OnLine · article · 2026
Abstract
Depressive and anxiety disorders are major causes of disability, while current treatments are often limited by delayed or incomplete response, relapse, side effects, and unequal access. The microbiota–gut–brain axis enables bidirectional communication between intestinal microbes and the brain through immune, neural, endocrine, metabolic, and barrier-related pathways. Studies link these disorders to microbial and metabolic alterations, including changes in butyrate-producing bacteria, inflammatory activity, short-chain fatty acids, and tryptophan metabolism. However, findings vary considerably, and no disorder-specific microbial profile has been established.
Improving diet currently has the strongest clinical relevance, while selected probiotics may offer adjunctive benefits. Evidence for prebiotics, synbiotics, postbiotics, and fecal microbiota transplantation remains limited, with transplantation still experimental in psychiatry. Further standardized longitudinal studies and mechanistic clinical trials are needed before microbiome-based interventions can enter routine care.
Open the resolved locator · 10.69980/1
Metadata licence: OpenAlex metadata (CC0)